![]() |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Lista delle Categorie
AlcolismoAlzheimer E ParkinsonAnalgesiciAntiallergicoAntibioticiAnticonvulsiviAntidepressiviAntimicoticiAntinfiammatoriAntiparassitariaAntiviraliApparato RespiratorioArtriteAsmaChirurgiaColesteroloContraccettivoCura Della PelleCura Per Gli OcchiDiabeteDisfunzione ErettileDisordini MentaliDiureticiEmicraniaFarmaci Anti- H I VMalattie CardiovascolariMalattie Genito-urinarieMalattie NeurologicheOsteoporosiPerdita Di PesoPressione Arteriosa SistemicaRilassanti MuscolariSalute Dell' UomoSalute Della DonnaTratto GastrointestinaleTumore 15 May 2012 20:12:30
Việc sá» dụng thuốc chống trầm cảmViá c sá dá ng thuá c chá ng trá m cá m VOA Tiá ng Viá t Nhá ng thuá c thÆ á ng gá p là fluoxetin (Prozac, Sarafem), sertralin (Zoloft), paroxetin (Paxil), fluvoxamin ( Luvox ). Theo khuyá n cà o hiá n nay cá a Tá chá c Y tá Quá c tá (WHO), là c chá a cÆ n trá m cá m bá ng thuá c, ná u thuá c hiá u nghiá m ngÆ á i ta cho bá nh nhà n ...
09 May 2012 16:58:15
Jazz Pharmaceuticals Announces First Quarter 2012 Financial ResultsJazz Pharmaceuticals Announces First Quarter 2012 Financial Results Sacramento Bee Psychiatry Products: Net sales of the company's psychiatry products, including once-daily Luvox CRÂ (fluvoxamine maleate), FazaClo HD and FazaClo LD were $17.7 million for the first quarter of 2012. For the prior year period, net sales of psychiatry ...
08 May 2012 22:08:54
Jazz Pharmaceuticals Announces First Quarter 2012 Financial ResultsJazz Pharmaceuticals Announces First Quarter 2012 Financial Results MarketWatch (press release) Psychiatry Products: Net sales of the company's psychiatry products, including once-daily Luvox CRÂ (fluvoxamine maleate), FazaClo HD and FazaClo LD were $17.7 million for the first quarter of 2012. For the prior year period, net sales of psychiatry ...
08 May 2012 22:07:12
Jazz Pharmaceuticals Announces First Quarter 2012 Financial ResultsJazz Pharmaceuticals Announces First Quarter 2012 Financial Results PR Newswire (press release) Psychiatry Products: Net sales of the company's psychiatry products, including once-daily Luvox CRÂ (fluvoxamine maleate), FazaClo HD and FazaClo LD were $17.7 million for the first quarter of 2012. For the prior year period, net sales of psychiatry ...
01 May 2012 01:43:07
Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference ...Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference ... MarketWatch (press release) The company's marketed products in these areas include: Xyrem (sodium oxybate), Prialt (ziconotide intrathecal infusion), FazaClo (clozapine USP) HD and LD, Luvox CR (fluvoxamine maleate) and Elestrin (estradiol gel 0.06%).
27 Apr 2012 13:24:36
Jazzed up for M&A, VCs Get a ReturnJazzed up for M&A, VCs Get a Return Private Equity Hub (press release) The company's marketed products in these areas include: Xyrem (sodium oxybate), Prialt (ziconotide intrathecal infusion), FazaClo (clozapine USP) HD and LD, Luvox CR (fluvoxamine maleate) and Elestrin (estradiol gel 0.06%).
26 Apr 2012 22:17:15
Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA PharmaJazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma MarketWatch (press release) The company's marketed products in these areas include: Xyrem (sodium oxybate), Prialt (ziconotide intrathecal infusion), FazaClo (clozapine USP) HD and LD, Luvox CR (fluvoxamine maleate) and Elestrin (estradiol gel 0.06%).
|
|
Choose Your language:
Cerca nel sito:
Testimonianze
Buon giorno:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| I più venduti|Politiche|Domande frequenti|Testimonianze|Contatti|Sitemap |
|
|
|
|
| |